High-dose therapy and ASCT versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: Long term results

被引：0
|
作者：
Carella, A. M. [1 ]
Bellei, M. [2 ]
Brice, P. [3 ]
Gisselbrecht, C. [3 ]
Visani, G. [4 ]
Colombat, P. [5 ]
Fabbiano, F. [6 ]
Donelli, A. [7 ]
Feugier, P. [8 ]
Browett, P. [9 ]
Hagberg, H. [10 ]
Federico, M. [2 ]
机构：
[1] Osped San Martino Genova, Div Ematol 1, Genoa, Italy
[2] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[3] Hop St Louis, Inst Hematol, Paris, France
[4] Osped San Salvatore, Div Ematol, Pesaro, Italy
[5] Ctr Hop Bretonneau, Serv Oncol Med & Malad Sang, Tours, France
[6] Osped Cervello, Div Ematol, Palermo, Italy
[7] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[8] Univ Hosp Nancy, Dept Hematol Internal Med, Nancy, France
[9] Univ Auckland, Mol Hematol & Lab Med, Auckland 1, New Zealand
[10] Uppsala Univ, Dept Radiol & Clin Immunol, S-75105 Uppsala, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] RESULTS OF THERAPY OF PREGNANT PATIENTS WITH HODGKIN'S LYMPHOMA
    Moiseeva, T. N.
    Al-Radi, L. S.
    Shitareva, I., V
    Dzhulakyan, U. L.
    Sharkunov, N. N.
    Skidan, N., I
    Kravchenko, S. K.
    Shmakov, R. G.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (02): : 39 - 43
  • [32] Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).
    Feldman, T.
    Mato, A. R.
    Zielonka, T.
    Masood, A.
    Goldberg, S.
    Rowley, S. D.
    Donato, M.
    Siegel, D. S.
    Pecora, A.
    Goy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] High-dose therapy with purged autologous stem cell transplantation (ASCT) as firstline therapy for follicular lymphoma.
    Wattad, M
    Lange, E
    Erbers, S
    Balleisen, L
    Heit, W
    BLOOD, 2000, 96 (11) : 376B - 376B
  • [34] Excellent long term survival of front-line high-dose chemotherapy with rituximab (HDT) in
    Dilhuydy, M.
    Lamy, T.
    Casassus, P.
    Deconninck, E.
    Gressin, R.
    Le Maignan, C.
    Milpied, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 147 - 148
  • [35] Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG
    Olivieri, A
    Santini, G
    Patti, C
    Chisesi, T
    De Souza, C
    Rubagotti, A
    Aversa, S
    Billio, A
    Porcellini, A
    Candela, M
    Centurioni, R
    Congiu, AM
    Brunori, M
    Nati, S
    Spriano, M
    Vimercati, R
    Marino, G
    Contu, A
    Tedeschi, L
    Majolino, I
    Crugnola, M
    Sertoli, MR
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1941 - 1948
  • [36] EFFECT OF DURATION OF FIRST REMISSION ON LONG-TERM OUTCOME OF HODGKIN LYMPHOMA PATIENTS UNDERGOING HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (HD-ASCT)
    Gerrie, A. S.
    Power, M. M.
    Savage, K. J.
    Shepherd, J. D.
    Connors, J. M.
    ANNALS OF ONCOLOGY, 2011, 22 : 168 - 168
  • [37] Long-term results of dose density therapy in patients with aggressive lymphoma
    Michael A. Fridrik
    Hubert Hausmaninger
    Werner Linkesch
    Richard Greil
    Otto Krieger
    Christian Baldinger
    Joerg Klocker
    Joerg Pont
    Willhelm Oberaigner
    Annals of Hematology, 2005, 84 : 217 - 222
  • [38] Long-term results of dose density therapy in patients with aggressive lymphoma
    Fridrik, M
    Hausmaninger, H
    Linkesch, W
    Greil, R
    Krieger, O
    Baldinger, C
    Klocker, J
    Pont, J
    Oberaigner, W
    ANNALS OF HEMATOLOGY, 2005, 84 (04) : 217 - 222
  • [39] Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy
    Weber, Damien C.
    Murray, Fritz
    Combescure, Christophe
    Calugaru, Valentin
    Alapetite, Claire
    Albertini, Francesca
    Bolle, Stephanie
    Goudjil, Farid
    Pica, Alessia
    Walser, Marc
    Mammar, Hamid
    Bachtiary, Barbara
    Lomax, Tony
    Noel, Georges
    Dendale, Remi
    Feuvret, Loic
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (03) : 520 - 526
  • [40] High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma
    Haas, R
    Murea, S
    Goldschmidt, H
    Dohner, H
    Moos, M
    Witt, B
    Eugenhart, R
    Wannenmacher, M
    Hunstein, W
    STEM CELLS, 1995, 13 : 28 - 35
12345